Full-Time
Posted on 6/11/2025
Develops and commercializes biopharmaceuticals and vaccines
No salary listed
Mid
Bengaluru, Karnataka, India
Flexible work environment, including hybrid working
Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a strong pipeline with plans for multiple product launches in the coming years. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized and environmental risks are managed.
Company Size
10,001+
Company Stage
IPO
Headquarters
Tokyo, Japan
Founded
1781
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Sick Leave
Wellness Program
Tuition Reimbursement
LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the World for 2024, achieving the No. 8 global ranking by both Ukraine and Bulgaria countries.
Takeda at ASH 2024: Phuong Khanh Morrow from Takeda in a riveting conversation with pharmashots.
At ISPOR 2025 in Montreal, its team at Value Analytics Labs - in collaboration with Takeda Pharmaceuticals - presented groundbreaking research on the use of generative AI in health economics.
The platform will integrate Salesforce's cutting-edge AI capabilities with Takeda's deep expertise in pharmaceuticals to enhance engagement with both patients and healthcare providers.
Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.